Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

CompletedOBSERVATIONAL
Enrollment

381

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Compensated Advanced Chronic Liver DiseaseVariceal Hemorrhage
Interventions
PROCEDURE

Esophagogasrtoduodendoscopy, spleen stiffness measurement and liver stiffness measurement.

Time frame between elastography measurement and esophagogastroduodendoscopy is within 2 weeks.

Trial Locations (6)

Unknown

Guangxi Zhuang Autonomous Region, Guangxi

Lanzhou University, Lanzhou

The Central Hospital of Lishui City, Lishui

Sixth People's Hospital of Shenyang, Shenyang

Tianjin Second People's Hospital, Tianjin

Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region, Xi'zang

All Listed Sponsors
collaborator

LanZhou University

OTHER

collaborator

Tianjin Second People's Hospital

OTHER

collaborator

The Sixth People's Hospital of Shenyang

OTHER

collaborator

Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region

UNKNOWN

collaborator

The Central Hospital of Lishui City

OTHER

collaborator

Guangxi Zhuang Autonomous Region

UNKNOWN

lead

Hepatopancreatobiliary Surgery Institute of Gansu Province

OTHER

NCT04546360 - Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004) | Biotech Hunter | Biotech Hunter